[Implantation of Reveal LINQ in Different Italian Scenarios: How to Further Improve?]

2024-5-31

Optimizing Treatment of Schizophrenia: Clinical and Economical Potential for Patient Switching to Long‑Acting Injectables

2024-4-22

[Cost per Responder Analysis of Filgotinib in Patients Suffering from Ulcerative Colitis]

2024-3-28

[Cost-Effectiveness Analysis of Maribavir in Patients with Post-Transplant Cytomegalovirus Infection or Disease that are Refractory or Resistant to Conventional Therapy]

2023-12-7

The Importance of the Pharmacoeconomic Analyses in Drug Negotiation. A Farewell Editorial

2023-10-4

HTA dei dispositivi di controllo urinario artificiale per il trattamento dell’incontinenza urinaria maschile grave post-prostatectomia

2023-5-15

[Measurement-Based Procurement Approach for Biosimilars in Italy: A Position Paper]

2023-3-29

[Burden of Short Bowel Syndrome in Italy: Direct and Indirect Costs and Quality of Life]

2023-3-24

Cost-effectiveness of Empagliflozin, in Addition to Metformin, in Patients with Type 2 Diabetes in Italy

2022-12-23

[Budget Impact Analysis of the Adjuvanted Quadrivalent Influenza Vaccine in the Elderly in Italy]

2022-11-30

Economic Consequences of Administering Obinutuzumab as a Short Duration Infusion in Italian Patients with Advanced Follicular Lymphoma: A Cost Analysis

2022-11-7

[Cost-Utility Analysis of Dupilumab for the Treatment of Severe Atopic Dermatitis in Children and Adolescents in Italy]

2022-6-22

Artificial Urinary Sphincters as a Treatment for Post-Prostatectomy Severe Urinary Incontinence in Italy: A Cost-Utility Analysis

2022-5-19

The Importance of Real-World Evidence in Understanding Influenza Vaccine Effectiveness

2022-3-3

Cost-Effectiveness of Dimethyl Fumarate Compared to Teriflunomide for Relapsing Remitting Multiple Sclerosis Patients in Italy

2022-2-7

Budget Saving Potential of Pegfilgrastim Biosimilar for the Treatment of Chemotherapy-Induced Febrile Neutropenia, in Italy

2022-2-2

[The Multidisciplinary Management of Type 2 Diabetes: an Integrated Care Model]

2021-9-29

A Budget Impact Analysis of the VENTANA PD-L1 SP142 Immunohistochemistry Assay Versus the Dako PD-L1 IHC 22C3 Assay in Patients With Advanced or Metastatic Triple-Negative Breast Cancer Treated With Atezolizumab in Combination With Nab-Paclitaxel

2021-7-26

Cost-Effectiveness Analysis of Alirocumab in High Cardiovascular-Risk Patients in Italy

2021-6-18

Osteoarthritis in Italy: Impact on Health-Related Quality of Life and Health Care Resources

2021-4-20

Health Technology Assessment on the use of the Wearable Cardioverter Defibrillator in Patients with Myocardial Infarction and with ICD Explant

2021-4-15

Clinical and Economic Rationale for the Early use of SGLT2 Inhibitors in Patients with Type 2 Diabetes

2020-12-23

Analysis of Market Access Agreements in Turkey

2020-10-22

Extended Half-life rFVIII for the Treatment of Hemophilia A: Drugs Consumption and Patients’ Perspective

2020-6-10

The Economic Burden of Different Multiple Sclerosis Courses: Analysis from Italian Administrative and Clinical Databases

2020-6-5

Funding Innovation Thanks to Anti-TNF-α Biosimilars Uptake: The Economic Impact in Italy

2020-5-7

Corrigendum: An Integrated Management Model of Patients With Atrial Fibrillation: The Experience of the Local Health Unit Tuscany North-West/2

2020-4-21

Critical Review of the Pivotal Studies of Four rFVIII Products for the Treatment of Hemophilia A Patients: The Role of Octocog Alfa

2020-4-3

Corrigendum: An Integrated Management Model of Patients With Atrial Fibrillation: The Experience of the Local Health Unit Tuscany North-West/1

2020-2-12

Real-life Diagnostic and Therapeutic Approach to CLL: A New Proposal from an Expert Panel in Tuscany Region

2020-2-6

Clinical Impact of two Different Diagnostic Strategies in the First- and Second-Line Treatment of Locally Advanced or Metastatic EGFR-Mutated Non-Small Cell Lung Cancer

2020-2-6

An Integrated Management Model of Patients With Atrial Fibrillation: The Experience of the Local Health Unit Tuscany North-West

2019-12-20

Evaluation of patients treated for diabetic retinopathy: an analysis of the administrative databases of the Lazio Region

2019-11-8

Developing a Model for the Establishment of Pre-Hospital Emergency Medicine Bases in the Northern Provinces of Iran

2019-10-7

Cost-Effectiveness Analysis of Dimethyl Fumarate in the Treatment of Relapsing Remitting Multiple Sclerosis: An Italian Societal Perspective

2019-7-30

The Value and Sustainability of Ocrelizumab in Relapsing Multiple Sclerosis: A Cost-Effectiveness and Budget Impact Analysis

2019-7-10

The Management of Psoriatic Arthritis in Italy: Organizational Impact Analysis of Optimized Pathwaystimized pathways

2019-7-2

Corrigendum: Treatments of Advanced Non‑Small Cell Lung Cancer (NSCLC) in an Italian Center: Drug Utilization and the Treatment Costs of Innovative Drugs

2019-6-5

Cost Minimization Analysis of Radiofrequency Compared to Laser Thermal Ablation in Patients with Hepatocellular Carcinoma

2019-4-19

Treatments of Advanced Non‑Small Cell Lung Cancer (NSCLC) in an Italian Center: Drug Utilization and the Treatment Costs of Innovative Drugs

2019-3-29

Acknowledgement to Reviewers (January - December 2018)

2019-2-15

Editorial Staff Disclosure (2018)

2019-2-15

Erratum: Effectiveness of Long-Acting Injectable Antipsychotics in Schizophrenia: A Literature Review and Bayesian Meta-Analysis Informing Economic Considerations

2019-2-13

Effectiveness of Long-Acting Injectable Antipsychotics in Schizophrenia: A Literature Review and Bayesian Meta-Analysis Informing Economic Considerations

2019-2-1

Economic Evaluation of Different Organizational Models for the Management of Patients with Hepatitis C

2019-1-28

Cost-Effectiveness Analysis of Peginterferon Beta-1a in the Treatment of Relapsing-Remitting Multiple Sclerosis in Italy: Results of an Updated Analysis

2018-11-30

Healthcare Resources Use in Patients with Human Immunodeficiency Virus (HIV). Real-World Evidence From Six Italian Local Health Units

2018-7-11

Cost-Consequence Analysis of Three Different Diagnostic Strategies in the First- and Second-Line Treatment of Locally Advanced or Metastatic Non-Small-Cell Lung Cancer

2018-5-23

Personalized medicine: biomarkers and companion diagnostics

2018-3-8

Estimating the cost-effectiveness of treatment for prevention of thromboembolic events in at-risk adults with non-valvular atrial fibrillation

2018-2-27